Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             51 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Appendix 2001
45 1-3 p. I-XIV
nvt p.
artikel
2 Assessment of teratogenic risk Battino, Dina
2001
45 1-3 p. 171-173
3 p.
artikel
3 Assessment of teratogenic risk design and status of the North American antiepileptic drug registry Holmes, Lewis B
2001
45 1-3 p. 175-176
2 p.
artikel
4 author index 2001
45 1-3 p. 177-178
2 p.
artikel
5 Cognitive and behavioural assessment in clinical trials: when should they be done? Thompson, Pam
2001
45 1-3 p. 159-161
3 p.
artikel
6 Cognitive and behavioural assessment in clinical trials: when should they be done? Aldenkamp, Albert P.
2001
45 1-3 p. 155-157
3 p.
artikel
7 Cognitive and behavioural assessments in clinical trials: what type of measure? Baker, Gus A
2001
45 1-3 p. 163-167
5 p.
artikel
8 Cognitive and behavioural assessments in clinical trials: what type of study? — What type of measure? Gillham, Ruth
2001
45 1-3 p. 169-170
2 p.
artikel
9 Comparative trials: equivalence and differences in clinical trials Mattson, Richard H
2001
45 1-3 p. 105-107
3 p.
artikel
10 contents 2001
45 1-3 p. 183-184
2 p.
artikel
11 Do we need any more new antiepileptic drugs? Brodie, Martin J.
2001
45 1-3 p. 3-6
4 p.
artikel
12 General discussion Richens, Alan
2001
45 1-3 p. 41-
1 p.
artikel
13 Instructions to authors 2001
45 1-3 p. 181-182
2 p.
artikel
14 Monotherapy comparative trials: equivalence and differences in clinical trials Chadwick, David
2001
45 1-3 p. 101-103
3 p.
artikel
15 Monotherapy comparative trials: placebos and suboptimal comparators Chadwick, David
2001
45 1-3 p. 97-99
3 p.
artikel
16 Monotherapy comparative trials: placebos and suboptimal comparators Schwabe, Stefan
2001
45 1-3 p. 93-96
4 p.
artikel
17 Monotherapy studies: conversion versus de novo Baulac, Michel
2001
45 1-3 p. 79-80
2 p.
artikel
18 Monotherapy trial design: conversion versus de novo Kälviäinen, Reetta
2001
45 1-3 p. 75-78
4 p.
artikel
19 Monotherapy trials: endpoints Mattson, Richard H
2001
45 1-3 p. 109-117
9 p.
artikel
20 Monotherapy trials: endpoints Chadwick, David
2001
45 1-3 p. 119-
1 p.
artikel
21 Monotherapy trials: endpoints Whitehead, John
2001
45 1-3 p. 121-122
2 p.
artikel
22 Monotherapy trials: prerequisite data Ben-Menachem, Elinor
2001
45 1-3 p. 65-66
2 p.
artikel
23 Monotherapy trials: prerequisite data Brodie, Martin J.
2001
45 1-3 p. 61-64
4 p.
artikel
24 Monotherapy trials: presurgical studies Pledger, Gordon
2001
45 1-3 p. 67-71
5 p.
artikel
25 Monotherapy trials: presurgical studies Binnie, Colin D
2001
45 1-3 p. 73-74
2 p.
artikel
26 Monotherapy trials: sequential design Holdich, Tom
2001
45 1-3 p. 89-91
3 p.
artikel
27 Monotherapy trials: sequential design Whitehead, John
2001
45 1-3 p. 81-87
7 p.
artikel
28 Preface French, Jacqueline A.
2001
45 1-3 p. 1-
1 p.
artikel
29 Proof of efficacy studies: endpoints Johnson, Tony
2001
45 1-3 p. 57-59
3 p.
artikel
30 Proof of efficacy trials: choosing the dose Pledger, Gordon
2001
45 1-3 p. 23-28
6 p.
artikel
31 Proof of efficacy trials: choosing the dose Schwabe, Stefan
2001
45 1-3 p. 29-30
2 p.
artikel
32 Proof of efficacy trials: cross-over versus parallel-group Richens, Alan
2001
45 1-3 p. 43-47
5 p.
artikel
33 Proof of efficacy trials: crossover versus parallel-group studies Johnson, Tony
2001
45 1-3 p. 49-51
3 p.
artikel
34 Proof of efficacy trials: endpoints French, Jacqueline A.
2001
45 1-3 p. 53-56
4 p.
artikel
35 Proof of efficacy trials: seizure types Schmidt, Dieter
2001
45 1-3 p. 35-36
2 p.
artikel
36 Proof of efficacy trials: seizure types Ben-Menachem, Elinor
2001
45 1-3 p. 31-34
4 p.
artikel
37 Proof of principle trials: EEG surrogate endpoints Binnie, Colin
2001
45 1-3 p. 7-11
5 p.
artikel
38 Proof of principle trials: EEG surrogate endpoints Richens, Alan
2001
45 1-3 p. 13-14
2 p.
artikel
39 Proof of principle trials: exploratory open studies Schmidt, Dieter
2001
45 1-3 p. 15-18
4 p.
artikel
40 Proof of principle trials: exploratory open studies Pierce, Mark W
2001
45 1-3 p. 19-21
3 p.
artikel
41 Seizure types and syndromes: lumping or splitting Dulac, Olivier
2001
45 1-3 p. 37-40
4 p.
artikel
42 Subject index 2001
45 1-3 p. 179-
1 p.
artikel
43 Trial duration and follow-up Perucca, Emilio
2001
45 1-3 p. 123-127
5 p.
artikel
44 Trial duration and follow-up Pierce, Mark W
2001
45 1-3 p. 129-131
3 p.
artikel
45 Trials in children Cross, Helen
2001
45 1-3 p. 139-140
2 p.
artikel
46 Trials in children Besag, Frank M.C.
2001
45 1-3 p. 137-138
2 p.
artikel
47 Trials in children Amann, J.P.
2001
45 1-3 p. 133-136
4 p.
artikel
48 Trials in the elderly Perucca, Emilio
2001
45 1-3 p. 149-151
3 p.
artikel
49 Trials in the elderly Brodie, Martin
2001
45 1-3 p. 153-154
2 p.
artikel
50 Trials in women Battino, Dina
2001
45 1-3 p. 141-145
5 p.
artikel
51 Trials in women Perucca, Emilio
2001
45 1-3 p. 147-
1 p.
artikel
                             51 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland